2,6-bis(benzimidazol-2-yl)pyridine
structure in first source
Also Known As:
2,6-bis(2-benzimidazolyl)pyridine
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Aydinlik, Seyma:
2 articles
(06/2020 - 01/2020)
|
| 2. | Aygun, Muhittin:
2 articles
(06/2020 - 01/2020)
|
| 3. | Icsel, Ceyda:
2 articles
(06/2020 - 01/2020)
|
| 4. | Yilmaz, Veysel T:
2 articles
(06/2020 - 01/2020)
|
| 5. | Froeyen, Mathy:
1 article
(06/2014)
|
| 6. | Haegeman, Andy:
1 article
(06/2014)
|
| 7. | Koenen, Frank:
1 article
(06/2014)
|
| 8. | Leyssen, Pieter:
1 article
(06/2014)
|
| 9. | Musiu, Simone:
1 article
(06/2014)
|
| 10. | Neyts, Johan:
1 article
(06/2014)
|
Related Diseases
| 1. | Lung Neoplasms (Lung Cancer)
06/16/2020
- " Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis." 01/01/2020
- " Correction for 'Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis' by Ceyda Icsel et al., Dalton Trans., 2020, 49, 7842-7851, DOI: ." 01/01/2020
- " Correction: Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis."
|
| 2. | Diarrhea
|
|
Related Drugs and Biologics